1. There was no procedure-related mortality or life-threatening events reported. 2. At the 6-month follow-up, improved valve function was noted with increased mean aortic valve area and decreased mean pressure gradient. Evidence Rating Level: 2 (Good) Study Rundown: Calcific aortic stenosis is often challenging to treat with conventional interventions given the burden of comorbidities among
Optimizing Treatment for Acute Spinal Cord Injury miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Medtronic India, in partnership with Docplexus, recently concluded the grand finale of India s Next Sushruta (INS), a case study competition aimed towards post-graduates and super-specialty students in the field of surgery.
Named after the Father of Early Surgery, Sushruta, INS, is a one-of-a-kind industry-academia program in the field of Indian medical technology, which saw participation from across specialties, including Oncology, General Surgery and Gastroenterology.
The finale of this competition saw Dr Usha H, MCh Surgical Oncology from Kidwai Memorial Institute of Oncology, Bangalore, win over the jury with her presentation to claim the title of India s Next Sushruta. Generally, there are not many platforms where young surgeons are encouraged to show their abilities. INS was indeed a great opportunity for every participant all across the country, and thanks to the head of my department, who made sure we participated in this event, said Dr Usha, whe
Madan Krishnan, Vice President & Managing Director, India Medtronic Pvt Ltd.
Straddling highly sophisticated medical technology on one hand and the revolutionary potential of a digitized world on the other, the healthcare industry is one that is evolving constantly. Recent developments in science and technology have made the unthinkable a reality, from remote monitoring devices to wearable technology, and if current trends are anything to go by, the future looks promising.
The emergence of innovative and path-breaking advancements in patient care is largely dependent on collaborative work between healthcare professionals (HCPs) and med-tech companies. They form the two pillars that guide the development of any new therapy, interacting at every stage, from conducting research and clinical studies, formulating early designs, to supporting medical education that counsels practitioners about the safe and effective usage of technologies.